Androgen treatment and muscle strength in elderly men: A meta-analysis

Kenneth Ottenbacher, Margaret E. Ottenbacher, Allison J. Ottenbacher, Ana Alfaro Acha, Glenn V. Ostir

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

OBJECTIVES: To review published, randomized trials examining the effect of androgen treatment on muscle strength in older men. DESIGN: Systematic review using meta-analysis procedures. SETTING: Computerized and manual searches. PARTICIPANTS: MEDLINE, EMBASE, CINAHL, and the Cochrane Register were searched for trials. Key words included testosterone, androgen, sarcopenia, muscle loss, aged, aging, elderly, older, geriatric, randomized controlled trials, and controlled clinical trials. Sixty-five nonoverlapping studies were found. Meta-analysis methods were used to evaluate the 11 randomized, double-blind trials. INTERVENTION: Testosterone or dihydrotestosterone (DHT) replacement therapy in healthy men aged 65 and older. MEASUREMENTS: Tests of muscle strength. RESULTS: The studies included 38 statistical comparisons. The mean g-index (gi) adjusted for sample size was 0.53 (95% confidence interval (CI)=0.21-0.86). Subanalyses revealed larger effects for measures of lower extremity muscle strength (gi=0.63, 95% CI=0.03-1.28) than for upper extremity muscle strength (gi=0.47, 95% CI=0.12-0.84). A larger mean g-index was found for injected (gi=0.95, 95% CI=0.33-1.58) than topical (gi=0.26, 95% CI=0.08-0.42) or oral (gi=-0.21, 95% CI=-1.40-1.02) administration of testosterone/DHT. Effect sizes were related to study characteristics such as subject attrition and design-quality ratings. Sensitivity analyses revealed that the elimination of one study reduced the mean g-index from 0.53 to 0.23. CONCLUSION: The results suggest that testosterone/DHT therapy produced a moderate increase in muscle strength in men participating in 11 randomized trials. One study influenced the mean effect size.

Original languageEnglish
Pages (from-to)1666-1673
Number of pages8
JournalJournal of the American Geriatrics Society
Volume54
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Muscle Strength
Androgens
Meta-Analysis
Confidence Intervals
Testosterone
Dihydrotestosterone
Therapeutics
Sarcopenia
Controlled Clinical Trials
Upper Extremity
MEDLINE
Geriatrics
Sample Size
Lower Extremity
Randomized Controlled Trials
Muscles

Keywords

  • Evaluation
  • Exercise
  • Hormone
  • Testosterone

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Androgen treatment and muscle strength in elderly men : A meta-analysis. / Ottenbacher, Kenneth; Ottenbacher, Margaret E.; Ottenbacher, Allison J.; Acha, Ana Alfaro; Ostir, Glenn V.

In: Journal of the American Geriatrics Society, Vol. 54, No. 11, 11.2006, p. 1666-1673.

Research output: Contribution to journalArticle

Ottenbacher, Kenneth ; Ottenbacher, Margaret E. ; Ottenbacher, Allison J. ; Acha, Ana Alfaro ; Ostir, Glenn V. / Androgen treatment and muscle strength in elderly men : A meta-analysis. In: Journal of the American Geriatrics Society. 2006 ; Vol. 54, No. 11. pp. 1666-1673.
@article{c144e329cd7e4c80ae1e72d9ff2617d3,
title = "Androgen treatment and muscle strength in elderly men: A meta-analysis",
abstract = "OBJECTIVES: To review published, randomized trials examining the effect of androgen treatment on muscle strength in older men. DESIGN: Systematic review using meta-analysis procedures. SETTING: Computerized and manual searches. PARTICIPANTS: MEDLINE, EMBASE, CINAHL, and the Cochrane Register were searched for trials. Key words included testosterone, androgen, sarcopenia, muscle loss, aged, aging, elderly, older, geriatric, randomized controlled trials, and controlled clinical trials. Sixty-five nonoverlapping studies were found. Meta-analysis methods were used to evaluate the 11 randomized, double-blind trials. INTERVENTION: Testosterone or dihydrotestosterone (DHT) replacement therapy in healthy men aged 65 and older. MEASUREMENTS: Tests of muscle strength. RESULTS: The studies included 38 statistical comparisons. The mean g-index (gi) adjusted for sample size was 0.53 (95{\%} confidence interval (CI)=0.21-0.86). Subanalyses revealed larger effects for measures of lower extremity muscle strength (gi=0.63, 95{\%} CI=0.03-1.28) than for upper extremity muscle strength (gi=0.47, 95{\%} CI=0.12-0.84). A larger mean g-index was found for injected (gi=0.95, 95{\%} CI=0.33-1.58) than topical (gi=0.26, 95{\%} CI=0.08-0.42) or oral (gi=-0.21, 95{\%} CI=-1.40-1.02) administration of testosterone/DHT. Effect sizes were related to study characteristics such as subject attrition and design-quality ratings. Sensitivity analyses revealed that the elimination of one study reduced the mean g-index from 0.53 to 0.23. CONCLUSION: The results suggest that testosterone/DHT therapy produced a moderate increase in muscle strength in men participating in 11 randomized trials. One study influenced the mean effect size.",
keywords = "Evaluation, Exercise, Hormone, Testosterone",
author = "Kenneth Ottenbacher and Ottenbacher, {Margaret E.} and Ottenbacher, {Allison J.} and Acha, {Ana Alfaro} and Ostir, {Glenn V.}",
year = "2006",
month = "11",
doi = "10.1111/j.1532-5415.2006.00938.x",
language = "English",
volume = "54",
pages = "1666--1673",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Androgen treatment and muscle strength in elderly men

T2 - A meta-analysis

AU - Ottenbacher, Kenneth

AU - Ottenbacher, Margaret E.

AU - Ottenbacher, Allison J.

AU - Acha, Ana Alfaro

AU - Ostir, Glenn V.

PY - 2006/11

Y1 - 2006/11

N2 - OBJECTIVES: To review published, randomized trials examining the effect of androgen treatment on muscle strength in older men. DESIGN: Systematic review using meta-analysis procedures. SETTING: Computerized and manual searches. PARTICIPANTS: MEDLINE, EMBASE, CINAHL, and the Cochrane Register were searched for trials. Key words included testosterone, androgen, sarcopenia, muscle loss, aged, aging, elderly, older, geriatric, randomized controlled trials, and controlled clinical trials. Sixty-five nonoverlapping studies were found. Meta-analysis methods were used to evaluate the 11 randomized, double-blind trials. INTERVENTION: Testosterone or dihydrotestosterone (DHT) replacement therapy in healthy men aged 65 and older. MEASUREMENTS: Tests of muscle strength. RESULTS: The studies included 38 statistical comparisons. The mean g-index (gi) adjusted for sample size was 0.53 (95% confidence interval (CI)=0.21-0.86). Subanalyses revealed larger effects for measures of lower extremity muscle strength (gi=0.63, 95% CI=0.03-1.28) than for upper extremity muscle strength (gi=0.47, 95% CI=0.12-0.84). A larger mean g-index was found for injected (gi=0.95, 95% CI=0.33-1.58) than topical (gi=0.26, 95% CI=0.08-0.42) or oral (gi=-0.21, 95% CI=-1.40-1.02) administration of testosterone/DHT. Effect sizes were related to study characteristics such as subject attrition and design-quality ratings. Sensitivity analyses revealed that the elimination of one study reduced the mean g-index from 0.53 to 0.23. CONCLUSION: The results suggest that testosterone/DHT therapy produced a moderate increase in muscle strength in men participating in 11 randomized trials. One study influenced the mean effect size.

AB - OBJECTIVES: To review published, randomized trials examining the effect of androgen treatment on muscle strength in older men. DESIGN: Systematic review using meta-analysis procedures. SETTING: Computerized and manual searches. PARTICIPANTS: MEDLINE, EMBASE, CINAHL, and the Cochrane Register were searched for trials. Key words included testosterone, androgen, sarcopenia, muscle loss, aged, aging, elderly, older, geriatric, randomized controlled trials, and controlled clinical trials. Sixty-five nonoverlapping studies were found. Meta-analysis methods were used to evaluate the 11 randomized, double-blind trials. INTERVENTION: Testosterone or dihydrotestosterone (DHT) replacement therapy in healthy men aged 65 and older. MEASUREMENTS: Tests of muscle strength. RESULTS: The studies included 38 statistical comparisons. The mean g-index (gi) adjusted for sample size was 0.53 (95% confidence interval (CI)=0.21-0.86). Subanalyses revealed larger effects for measures of lower extremity muscle strength (gi=0.63, 95% CI=0.03-1.28) than for upper extremity muscle strength (gi=0.47, 95% CI=0.12-0.84). A larger mean g-index was found for injected (gi=0.95, 95% CI=0.33-1.58) than topical (gi=0.26, 95% CI=0.08-0.42) or oral (gi=-0.21, 95% CI=-1.40-1.02) administration of testosterone/DHT. Effect sizes were related to study characteristics such as subject attrition and design-quality ratings. Sensitivity analyses revealed that the elimination of one study reduced the mean g-index from 0.53 to 0.23. CONCLUSION: The results suggest that testosterone/DHT therapy produced a moderate increase in muscle strength in men participating in 11 randomized trials. One study influenced the mean effect size.

KW - Evaluation

KW - Exercise

KW - Hormone

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=33750518404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750518404&partnerID=8YFLogxK

U2 - 10.1111/j.1532-5415.2006.00938.x

DO - 10.1111/j.1532-5415.2006.00938.x

M3 - Article

C2 - 17087692

AN - SCOPUS:33750518404

VL - 54

SP - 1666

EP - 1673

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 11

ER -